Today at HLTH 2018, a health care innovation conference taking place this week in Las Vegas, Nevada, CVS Health chief medical officer Dr. Troyen Brennan delivered a keynote address outlining CVS Health’s unique potential to help change current paradigms for addressing population health. Dr.
Fred’s Inc. has reported that CVS Health is purchasing its specialty pharmacy business EntrustRx for $40 million.
Diplomat Pharmacy announced financial results for the quarter ended March 31, 2018. All comparisons, unless otherwise noted, are to the quarter ended March 31, 2017.
BENTONVILLE, Ark. – In an effort to continue to be part of the solution to the nation’s opioid epidemic, Walmart is introducing new policies, programs and tools aimed at curbing opioid misuse and abuse.
For more than 35 years McKesson’s ideaShare has been the premier education and networking event for community pharmacies. The leading conference is designed to help independent pharmacy owners and their staff improve their knowledge, performance and profitability.
After 15 years of heading up the Pharmaceutical Care Management Association (PCMA), chief executive officer and president Mark Merritt is stepping down, effective at year-end. Under Merritt’s leadership, PCMA grew from an obscure group into the nation’s leading voice on prescription drug benefits.
Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. announced that they have completed their business combination to form Amneal Pharmaceuticals, Inc.
Boehringer Ingelheim announced that Praxbind (idarucizumab), a specific reversal agent for Pradaxa (dabigatran etexilate mesylate), is now stocked in 3,200 hospitals in all 50 states.
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of oxymorphone tablets to our growing portfolio of products. Oxymorphone tablets are the generic version of Opana from Endo Pharmaceuticals and is used to treat moderate to severe pain.
WASHINGTON – The role of National Association of Chain Drug Stores members in the conversation about improving healthcare and addressing related societal challenges was on display during the 15th Annual World Health Care Congress, held earlier this week here.
Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of Doxazosin tablets, USP, 1 mg, 2 mg, 4 mg and 8 mg. The product was approved by the U.S. Food and Drug Administration (FDA) on April 17, 2018.
Amneal Pharmaceuticals has launched vigabatrin for oral solution USP, a generic equivalent for Sabril. This is the second generic vigabatrin product currently on the market. Each carton contains fifty 500 mg packets. The finished dosage form is manufactured in the United States.
A nationwide consortium led by the National Institutes of Health (NIH) will launch the All of Us Research Program on Friday, May 6, which is being hailed as a pioneering research initiative that will use advance technologies and engage participants as citizen-scientists to embark on a new era of hea
Diplomat Pharmacy has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management.
ADHD. Methylphenidate chewable tablets are available in 2.5, 5 and 10mg 100 count bottles. The
McKesson Canada’s Rexall chain is closing 40 outlets in Ontario and Western Canada, nearly one-tenth of its total store base, according to a memo sent to company employees. The closings come about a year and a half after San Francisco-based McKesson Corp. finalized the purchase of Rexall Health.
